Novavax (NVAX) Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to EMA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. NVDA
7. BLZE
8. IBM
9. PRIM
10. ACN

Go back to Novavax (NVAX) Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to EMA

Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medicines Agency

November 1, 2021 6:20 AM EDT

Health Canada filing marks first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities in Canada Submission of all modules required for regulatory review, including CMC and clinical data, are now complete for European Medicines Agency

GAITHERSBURG, Md., Nov. 1, 2021 Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion of its rolling submission to Health Canada for authorization of its COVID-19 vaccine candidate, the first filing of a... More